Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Guido Wendel

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Clinical Advances in Hematology & Oncology : H&O|June 9, 2020
Emerging therapeutic targets in follicular lymphomaHans-Guido Wendel
Annals of the New York Academy of Sciences|May 17, 2013
Functional genomics lead to new therapies in follicular lymphomaElisa Oricchio, Hans-Guido Wendel
Molecular & Cellular Oncology|April 14, 2022
Genomic studies indicate a novel combination therapy for follicular lymphomaElisa Oricchio, Hans-Guido Wendel
Blood|March 30, 2023
The cat-and-mouse game of BTK inhibitionAna Portelinha, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|February 24, 2012
Mining the cancer genome uncovers therapeutic activity of EphA7 against lymphomaElisa Oricchio, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|September 13, 2008
Translational control and cancer therapyKonstantinos J Mavrakis, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|May 28, 2010
TargetScreen: an unbiased approach to identify functionally important microRNA targetsKonstantinos J Mavrakis, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|November 9, 2011
Targeted cancer therapy: what if the driver is just a messenger?Jonathan H Schatz, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|June 11, 2004
Reversing drug resistance in vivoHans-Guido Wendel, Scott W Lowe
Cell Cycle (Georgetown, Tex.)|February 8, 2008
MNK, EIF4E and targeting translation for therapyRicardo L A Silva, Hans Guido Wendel
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Clinical Advances in Hematology & Oncology : H&O|June 9, 2020
Emerging therapeutic targets in follicular lymphomaHans-Guido Wendel
Annals of the New York Academy of Sciences|May 17, 2013
Functional genomics lead to new therapies in follicular lymphomaElisa Oricchio, Hans-Guido Wendel
Molecular & Cellular Oncology|April 14, 2022
Genomic studies indicate a novel combination therapy for follicular lymphomaElisa Oricchio, Hans-Guido Wendel
Blood|March 30, 2023
The cat-and-mouse game of BTK inhibitionAna Portelinha, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|February 24, 2012
Mining the cancer genome uncovers therapeutic activity of EphA7 against lymphomaElisa Oricchio, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|September 13, 2008
Translational control and cancer therapyKonstantinos J Mavrakis, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|May 28, 2010
TargetScreen: an unbiased approach to identify functionally important microRNA targetsKonstantinos J Mavrakis, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|November 9, 2011
Targeted cancer therapy: what if the driver is just a messenger?Jonathan H Schatz, Hans-Guido Wendel
Cell Cycle (Georgetown, Tex.)|June 11, 2004
Reversing drug resistance in vivoHans-Guido Wendel, Scott W Lowe
Cell Cycle (Georgetown, Tex.)|February 8, 2008
MNK, EIF4E and targeting translation for therapyRicardo L A Silva, Hans Guido Wendel
Pageof 7